Nina Bhanap - QuinStreet CTO and President of Product and Technology
QNST Stock | USD 22.91 0.44 1.96% |
President
Ms. Nina Bhanap is Chief Technology Officer, President Product and Technology of the company since 2015.
Age | 51 |
Tenure | 9 years |
Professional Marks | MBA |
Address | 950 Tower Lane, Foster City, CA, United States, 94404 |
Phone | 650 587 7700 |
Web | https://www.quinstreet.com |
QuinStreet Management Efficiency
The company has return on total asset (ROA) of (0.0335) % which means that it has lost $0.0335 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1001) %, meaning that it created substantial loss on money invested by shareholders. QuinStreet's management efficiency ratios could be used to measure how well QuinStreet manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.14 in 2024. Return On Capital Employed is likely to gain to -0.11 in 2024. At this time, QuinStreet's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 36.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 82.1 M in 2024.Similar Executives
Found 11 records | PRESIDENT Age | ||
Samson Li | Phibro Animal Health | 52 | |
Rebecca Kitchens | TechTarget | 46 | |
Jonathan Bendheim | Phibro Animal Health | 48 | |
Adam Pollitzer | NMI Holdings | 44 | |
John Swenson | NMI Holdings | N/A | |
Ramon Fuenmayor | Phibro Animal Health | N/A | |
Thomas Dagger | Phibro Animal Health | 66 | |
Lisa Escudero | Phibro Animal Health | 62 | |
Michael Giambalvo | Phibro Animal Health | N/A | |
Rob Aukerman | Phibro Animal Health | 66 | |
Daniel Bendheim | Phibro Animal Health | 52 |
Management Performance
Return On Equity | -0.1 | ||||
Return On Asset | -0.0335 |
QuinStreet Leadership Team
Elected by the shareholders, the QuinStreet's board of directors comprises two types of representatives: QuinStreet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QuinStreet. The board's role is to monitor QuinStreet's management team and ensure that shareholders' interests are well served. QuinStreet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QuinStreet's outside directors are responsible for providing unbiased perspectives on the board's policies.
Douglas Valenti, President Chairman | ||
Peter Brooks, Senior President | ||
Nina Bhanap, CTO and President of Product and Technology | ||
Stephen Chen, Senior President | ||
Robert Amparo, Senior Finance | ||
Martin JD, Chief Officer | ||
Gregory Wong, CFO and Sr. VP | ||
Martin Collins, Chief Compliance Officer, Head of Corporate Devel., Sr. VP and General Counsel | ||
Ashley Heller, Chief Officer | ||
Jeremy Crisp, Senior Marketing | ||
Timothy JD, Chief Officer | ||
Hayden Blair, Sr Relations |
QuinStreet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is QuinStreet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.1 | ||||
Return On Asset | -0.0335 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.03 % | ||||
Current Valuation | 1.21 B | ||||
Shares Outstanding | 56.26 M | ||||
Shares Owned By Insiders | 4.43 % | ||||
Shares Owned By Institutions | 92.43 % | ||||
Number Of Shares Shorted | 1.82 M | ||||
Price To Earning | 24.39 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for QuinStreet Stock Analysis
When running QuinStreet's price analysis, check to measure QuinStreet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuinStreet is operating at the current time. Most of QuinStreet's value examination focuses on studying past and present price action to predict the probability of QuinStreet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuinStreet's price. Additionally, you may evaluate how the addition of QuinStreet to your portfolios can decrease your overall portfolio volatility.